Acquisition by Story Brooke of 2680 shares of LivaNova PLC subject to Rule 16b-3
LIVN Stock | USD 52.29 0.21 0.40% |
About 61% of LivaNova PLC's investor base is looking to short. The analysis of overall sentiment of trading LivaNova PLC stock suggests that many investors are alarmed at this time. LivaNova PLC's investing sentiment overview a quick insight into current market opportunities from investing in LivaNova PLC. Many technical investors use LivaNova PLC stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LivaNova |
Filed transaction by Livanova Plc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
LivaNova PLC Fundamental Analysis
We analyze LivaNova PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LivaNova PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LivaNova PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
LivaNova PLC is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
LivaNova PLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LivaNova PLC stock to make a market-neutral strategy. Peer analysis of LivaNova PLC could also be used in its relative valuation, which is a method of valuing LivaNova PLC by comparing valuation metrics with similar companies.
Peers
LivaNova PLC Related Equities
NPCE | Neuropace | 6.51 | ||||
CNMD | CONMED | 2.59 | ||||
LUNG | Pulmonx Corp | 1.24 | ||||
IRTC | IRhythm Technologies | 1.07 | ||||
BRKR | Bruker | 0.72 | ||||
FNA | Paragon 28 | 0.1 | ||||
KIDS | Orthopediatrics Corp | 0.19 | ||||
OFIX | Orthofix Medical | 1.13 | ||||
ITGR | Integer Holdings | 1.23 | ||||
SIBN | Si Bone | 1.40 | ||||
GMED | Globus Medical | 2.00 | ||||
ATEC | Alphatec Holdings | 2.58 | ||||
GKOS | Glaukos Corp | 3.18 |
Check out LivaNova PLC Hype Analysis, LivaNova PLC Correlation and LivaNova PLC Performance. To learn how to invest in LivaNova Stock, please use our How to Invest in LivaNova PLC guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LivaNova PLC. If investors know LivaNova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LivaNova PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LivaNova PLC is measured differently than its book value, which is the value of LivaNova that is recorded on the company's balance sheet. Investors also form their own opinion of LivaNova PLC's value that differs from its market value or its book value, called intrinsic value, which is LivaNova PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LivaNova PLC's market value can be influenced by many factors that don't directly affect LivaNova PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LivaNova PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if LivaNova PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LivaNova PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.